Validation of Stem-loop RT-qPCR Method on the Pharmacokinetic Analysis of siRNA Therapeutics
![]() |
Kim, Hye Jeong
(Division of Forest Science, Kangwon National University)
Kim, Taek Min (Department of Nano-Bioengineering, Incheon National University) Kim, Hong Joong (EnhancedBio Inc. R&D center) Jung, Hun Soon (EnhancedBio Inc. R&D center) Lee, Seung Ho (Department of Nano-Bioengineering, Incheon National University) |
1 | Jung, H., Rajasekaran, N., Song, S., Kim, Y., Hong, S., Choi, H. and Shin, Y. 2015. Human papillomavirus E6/ E7-specific siRNA potentiates the effect of radiotherapy for cervical cancer in vitro and in vivo. Int. J. Mol. Sci. 16, 12243-12260. DOI |
2 | Lam, J. K., Chow, M. Y. T., Zhang, Y. and Leung, S. W. 2015. siRNA versus miRNA as therapeutics for gene silencing. Mol. Ther. Nucleic Acids 4, e252. DOI |
3 | Liu, W., Stevenson, M., Seymour, L. W. and Fisher, K. D. 2008. Quantification of siRNA using competitive qPCR. Nucleic Acids Res. 37, e4. DOI |
4 | Luo, G. 2002. CYP3A4 induction by drugs: Correlation between a pregnane X receptor reporter gene assay and CYP 3A4 expression in human hepatocytes. Drug Metab. Dispos. 30, 795-804. DOI |
5 | Rizk, M. and Tuzmen, S. 2017. Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran. Pharmgenomics Pers. Med. 10, 267-278. |
6 | Thakur, A., Fitzpatrick, S., Zaman, A., Kugathasan, K., Muirhead, B., Hortelano, G. and Sheardown, H. 2012. Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers, J. Biol. Eng. 6, 7. DOI |
7 | Tremblay, G. A. and Oldfield, P. R. 2009. Bioanalysis of siRNA and oligonucleotide therapeutics in biological fluids and tissues. Bioanalysis 1, 595-609. DOI |
8 | Varkonyi-Gasic, E. and Hellens, R. P. 2011. Quantitative stem-loop RT-PCR for detection of microRNAs. Methods Mol. Biol. 744, 145-157. DOI |
9 | Wang, S. J., Wu, S. T., Gokemeijer, J., Fura, A., Krishna, M., Morin, P. and Jemal, M. 2011. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies. Anal. Bioanal. Chem. 402, 1229-1239. DOI |
10 | Zhang, J., Li, X. and Huang, L. 2014. Non-viral nanocarriers for siRNA delivery in breast cancer. J. Control. Release 190, 440-450. DOI |
11 | Hunt, E. A., Broyles, D., Head, T. and Deo, S. K. 2015. MicroRNA detection: Current technology and research strategies. Annu. Rev. Anal. Chem. 8, 217-237. DOI |
12 | Burnett, J. C., Rossi, J. J. and Tiemann, K. 2011. Current progress of siRNA/ shRNA therapeutics in clinical trials. Biotechnol. J. 6, 1130-1146. DOI |
13 | Cejka, D., Losert, D. and Wacheck, V. 2006. Short interfering RNA (siRNA): tool or therapeutic? Clin. Sci. 110, 47-58. DOI |
14 | Chakraborty, C., Sharma, A. R., Sharma, G., Doss, C. G. P. and Lee, S. S. 2017. Therapeutic miRNA and siRNA: Moving from bench to clinic as next generation medicine. Mol. Ther. Nucleic Acids 8, 132-143. DOI |
15 | Chen, C. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, 79-79. DOI |
16 | Fan, A. C., Goldrick, M. M., Ho, J., Liang, Y., Bachireddy, P. and Felsher, D. W. 2008. A quantitative PCR method to detect blood microRNAs associated with tumorigenesis in transgenic mice. Mol. Cancer 7, 74. DOI |
17 | Haasnoot, J., Westerhout, E. M. and Berkhout, B. 2007. RNA interference against viruses: Strike and counterstrike. Nat. Biotechnol. 25, 1435-1443. DOI |
18 | Hannon, G. J. 2002. RNA interference. Nature 418, 244-251. DOI |
19 | Jesse, S., Megan, B., Amanda, H., Annaleen, V., Melissa, L. K. and Anja, B. 2017. A new method for generating arrayed RNAi screening tools for any organism. GDI conference. September. London, England. |
![]() |